Moderna
MRNA
£20.68
Share price
8.24%
Change (1 day)
-76.51%
Change (1 year)
Moderna, Inc. is an American biotechnology company focused on the discovery and development of messenger RNA-based drugs.
Earnings for Moderna (MRNA)
Earnings in 2024 (TTM): -£2.85 Billion
According to Moderna 's latest financial reports the company's current earnings are £3.19 Billion. , an increase over its 2023 earnings that were of -£3.03 Billion. The earnings displayed on this page is the company's Pretax Income.
Earnings history for Moderna from 2018 to 2024
Annual earnings
| Year | Earnings | Change |
|---|---|---|
2024  | -£2.78 Billion | -8.22% |
| 2023 | -£3.03 Billion | -140.65% |
| 2022 | £7.44 B | -27.81% |
| 2021 | £10.31 B | -1911.15% |
| 2020 | -£0.57 Billion | 44.7% |
| 2019 | -£0.4 Billion | 28.63% |
| 2018 | -£0.31 Billion |
Earnings for similar companies or competitors
| Company | Earnings | Earnings differencediff. | Country |
|---|---|---|---|
 | -£35.83 Million | -98.71% | 🇺🇸 USA |
 | £16.44 B | -691.88% | 🇺🇸 USA |
 | -£32.39 Million | -98.83% | 🇺🇸 USA |
 | -£0.19 Billion | -93.43% | 🇺🇸 USA |
 | £10.57 B | -480.69% | 🇨🇭 Switzerland |
 | -£0.47 Billion | -83.25% | 🇺🇸 USA |
 | £13.52 B | -586.80% | 🇺🇸 USA |
 | -£91.24 Million | -96.72% | 🇺🇸 USA |